Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
Cellarity
Flagship Pioneering therapeutics company using single-cell data and AI models of cell behavior to discover medicines, engaged via pharma partnerships.
Cellarity, founded in 2017 by Flagship Pioneering and headquartered in Cambridge, Massachusetts, trains AI models on tens of millions of single-cell transcriptomes to model cell state and behavior, generating novel drug candidates. It runs an internal pipeline and engages pharma through partnerships rather than as a licensable software product, so engagement is collaboration-based. No public third-party security certifications were identified at profiling time.
- Headquarters
- Cambridge, United States
- Founded
- 2017
- Deployment options
- cloud
- Website
- https://cellarity.com
- https://www.linkedin.com/company/cellarity
Categories
AI Use Cases
- Target Identification & Validation
Vendor Scorecard
50% — Partial coverage. Coverage score — how completely Atlas documents Cellarity across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Deployment & Hosting — Documented
cloud
Pricing Transparency — Not documented by Atlas
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Implementation & Onboarding — Not documented by Atlas
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Organization & Role Fit — Documented
Large Pharma, Top 20 Pharma, Drug Discovery, R&D Leadership
Solution Scope — Documented
Biomarker Discovery, Target Identification
Company Viability — Partially documented
Series C, Founded 2017
Always ask the vendor
Not captured in Atlas data — confirm directly. Excluded from the score above.
Data Rights & IP
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Model Credibility & Explainability
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?
Questions to Ask This Vendor
- Is engagement always a partnership, or is any platform access licensable?
- Which therapeutic areas have active or completed programs?
- How are AI-generated hypotheses validated experimentally?
- How is IP structured in a collaboration?